Market revenue in 2022 | USD 251.5 million |
Market revenue in 2030 | USD 503.2 million |
Growth rate | 9.1% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.21% in 2022. Horizon Databook has segmented the Germany non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the major markets for non-invasive prenatal testing in Europe. Higher healthcare expenditure, high spending power, and improvisation in healthcare policies are some of the key factors driving Germany’s market over the forecast period.
In 2019, the pending NIPT national decision was made, which states that NIPT will now be covered under publicly funded insurance in Germany. This is expected to positively influence the non-invasive prenatal testing market in the country. However, it limits the usage to only certain circumstances of high-risk pregnancies.
Furthermore, some of the key players that offer NIPT products in the country are PrenaTest by LifeCodexx and Panorama Test by Natera distributed by Amedes. The presence of market players such as LifeCodexx AG, which provides noninvasive prenatal screening through PrenaTest, coupled with rising incidence of chromosomal abnormalities, is responsible for the larger revenue share of the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Germany non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account